Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medically Uninsured | 12 | 2022 | 843 | 3.210 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2021 | 1200 | 2.100 |
Why?
|
Health Services Accessibility | 16 | 2024 | 5366 | 1.970 |
Why?
|
Health Care Reform | 7 | 2022 | 1245 | 1.730 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 3207 | 1.640 |
Why?
|
Insurance Coverage | 12 | 2022 | 1939 | 1.630 |
Why?
|
Health Expenditures | 9 | 2024 | 2354 | 1.620 |
Why?
|
Asthma | 7 | 2023 | 6159 | 1.560 |
Why?
|
Prescription Drugs | 3 | 2021 | 630 | 1.220 |
Why?
|
Medicare Part C | 2 | 2024 | 316 | 1.220 |
Why?
|
United States | 51 | 2024 | 72238 | 1.190 |
Why?
|
Medicaid | 6 | 2021 | 2808 | 1.190 |
Why?
|
Medicare | 9 | 2024 | 6763 | 1.130 |
Why?
|
Healthcare Disparities | 8 | 2022 | 3364 | 1.000 |
Why?
|
Pandemics | 9 | 2023 | 8604 | 0.970 |
Why?
|
Insurance, Health | 7 | 2023 | 2500 | 0.960 |
Why?
|
Minority Health | 2 | 2021 | 80 | 0.860 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3088 | 0.830 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3208 | 0.820 |
Why?
|
Physicians | 4 | 2022 | 4583 | 0.800 |
Why?
|
Supreme Court Decisions | 1 | 2023 | 133 | 0.780 |
Why?
|
National Health Programs | 2 | 2023 | 442 | 0.760 |
Why?
|
Politics | 3 | 2021 | 815 | 0.750 |
Why?
|
Lung Transplantation | 2 | 2022 | 1299 | 0.740 |
Why?
|
Postal Service | 1 | 2021 | 94 | 0.740 |
Why?
|
Respiration Disorders | 1 | 2024 | 368 | 0.730 |
Why?
|
Ownership | 1 | 2023 | 335 | 0.710 |
Why?
|
Public Health | 3 | 2024 | 2656 | 0.710 |
Why?
|
Sick Leave | 1 | 2020 | 105 | 0.690 |
Why?
|
Health Care Rationing | 1 | 2022 | 432 | 0.660 |
Why?
|
Hospitalization | 5 | 2024 | 10732 | 0.650 |
Why?
|
Crowding | 1 | 2020 | 142 | 0.650 |
Why?
|
Financing, Government | 2 | 2023 | 472 | 0.640 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 285 | 0.640 |
Why?
|
Law Enforcement | 1 | 2020 | 112 | 0.640 |
Why?
|
Unemployment | 1 | 2020 | 210 | 0.640 |
Why?
|
Lung Diseases | 2 | 2022 | 1915 | 0.630 |
Why?
|
Costs and Cost Analysis | 2 | 2023 | 1674 | 0.630 |
Why?
|
Financial Management | 1 | 2020 | 161 | 0.620 |
Why?
|
Deductibles and Coinsurance | 2 | 2021 | 316 | 0.610 |
Why?
|
Coronavirus | 1 | 2020 | 150 | 0.610 |
Why?
|
Employment | 2 | 2023 | 1111 | 0.600 |
Why?
|
Public Health Administration | 1 | 2020 | 243 | 0.590 |
Why?
|
Communicable Disease Control | 2 | 2020 | 844 | 0.550 |
Why?
|
Pharmaceutical Services | 1 | 2018 | 141 | 0.550 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 499 | 0.540 |
Why?
|
Humans | 72 | 2024 | 759098 | 0.530 |
Why?
|
Health Care Surveys | 5 | 2022 | 2434 | 0.530 |
Why?
|
Single-Payer System | 1 | 2016 | 35 | 0.520 |
Why?
|
Diabetic Ketoacidosis | 1 | 2019 | 252 | 0.520 |
Why?
|
Cross-Sectional Studies | 16 | 2024 | 25853 | 0.520 |
Why?
|
Documentation | 1 | 2022 | 885 | 0.520 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2018 | 345 | 0.510 |
Why?
|
Influenza Vaccines | 1 | 2022 | 771 | 0.490 |
Why?
|
Vulnerable Populations | 1 | 2020 | 696 | 0.490 |
Why?
|
Lung | 5 | 2023 | 9980 | 0.470 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 507 | 0.470 |
Why?
|
Outpatients | 1 | 2022 | 1601 | 0.460 |
Why?
|
Transportation | 1 | 2015 | 214 | 0.460 |
Why?
|
Dyspnea | 2 | 2021 | 1352 | 0.450 |
Why?
|
Vaccination | 5 | 2024 | 3354 | 0.440 |
Why?
|
Health Status Disparities | 3 | 2021 | 1818 | 0.440 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1241 | 0.440 |
Why?
|
Ambulatory Care | 2 | 2021 | 2775 | 0.430 |
Why?
|
Socioeconomic Factors | 6 | 2024 | 7790 | 0.410 |
Why?
|
Patient Acceptance of Health Care | 3 | 2021 | 3152 | 0.410 |
Why?
|
Population Surveillance | 2 | 2020 | 2610 | 0.400 |
Why?
|
Urban Population | 2 | 2020 | 2015 | 0.400 |
Why?
|
Drug Industry | 1 | 2018 | 789 | 0.390 |
Why?
|
Health Surveys | 1 | 2021 | 4059 | 0.390 |
Why?
|
Disabled Persons | 1 | 2021 | 1226 | 0.380 |
Why?
|
Influenza, Human | 1 | 2022 | 1534 | 0.370 |
Why?
|
Prevalence | 7 | 2022 | 15639 | 0.370 |
Why?
|
Smoking | 4 | 2022 | 9066 | 0.370 |
Why?
|
Intensive Care Units | 3 | 2022 | 3730 | 0.360 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5310 | 0.350 |
Why?
|
Canada | 3 | 2022 | 2124 | 0.350 |
Why?
|
Rural Population | 1 | 2020 | 2260 | 0.350 |
Why?
|
Respiratory Tract Diseases | 1 | 2015 | 747 | 0.340 |
Why?
|
Medication Adherence | 1 | 2020 | 2161 | 0.300 |
Why?
|
Insulin | 1 | 2022 | 6589 | 0.300 |
Why?
|
Adult | 23 | 2024 | 219353 | 0.300 |
Why?
|
Respiratory Function Tests | 2 | 2023 | 1685 | 0.290 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1225 | 0.280 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5875 | 0.280 |
Why?
|
Social Class | 1 | 2016 | 2005 | 0.280 |
Why?
|
Occupational Diseases | 1 | 2015 | 1484 | 0.280 |
Why?
|
Workplace | 2 | 2023 | 854 | 0.280 |
Why?
|
Veterans | 1 | 2020 | 2628 | 0.260 |
Why?
|
Hospitals, Private | 1 | 2024 | 63 | 0.230 |
Why?
|
Health Services Needs and Demand | 3 | 2021 | 1394 | 0.230 |
Why?
|
Poverty | 3 | 2020 | 2679 | 0.220 |
Why?
|
Aged | 14 | 2024 | 168615 | 0.210 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3864 | 0.210 |
Why?
|
Hypertension | 1 | 2023 | 8582 | 0.210 |
Why?
|
Investments | 1 | 2024 | 148 | 0.210 |
Why?
|
Female | 22 | 2024 | 390174 | 0.210 |
Why?
|
Prisons | 1 | 2024 | 170 | 0.210 |
Why?
|
Spirometry | 2 | 2016 | 923 | 0.210 |
Why?
|
Health Policy | 1 | 2015 | 2674 | 0.200 |
Why?
|
Adolescent | 9 | 2024 | 87551 | 0.200 |
Why?
|
Physicians' Offices | 1 | 2022 | 60 | 0.200 |
Why?
|
Health Planning | 2 | 2021 | 231 | 0.200 |
Why?
|
Male | 21 | 2024 | 358602 | 0.200 |
Why?
|
Air Pollution | 1 | 2015 | 2318 | 0.200 |
Why?
|
Middle Aged | 15 | 2024 | 219628 | 0.190 |
Why?
|
Young Adult | 8 | 2024 | 58477 | 0.190 |
Why?
|
Budgets | 1 | 2023 | 230 | 0.190 |
Why?
|
Prisoners | 1 | 2024 | 310 | 0.190 |
Why?
|
Industry | 1 | 2023 | 360 | 0.190 |
Why?
|
Riot Control Agents, Chemical | 1 | 2020 | 3 | 0.180 |
Why?
|
Environmental Exposure | 1 | 2015 | 4389 | 0.180 |
Why?
|
Occupations | 1 | 2023 | 513 | 0.180 |
Why?
|
Censuses | 1 | 2021 | 201 | 0.170 |
Why?
|
Immunization, Secondary | 1 | 2022 | 366 | 0.170 |
Why?
|
China | 2 | 2016 | 2349 | 0.170 |
Why?
|
Morals | 1 | 2022 | 288 | 0.170 |
Why?
|
Absenteeism | 1 | 2020 | 250 | 0.160 |
Why?
|
Chronic Disease | 3 | 2024 | 9245 | 0.150 |
Why?
|
Hospital Bed Capacity | 1 | 2019 | 210 | 0.150 |
Why?
|
Office Visits | 1 | 2022 | 596 | 0.150 |
Why?
|
Hospital Costs | 1 | 2024 | 977 | 0.150 |
Why?
|
Respiration | 1 | 2024 | 1649 | 0.140 |
Why?
|
Hospitals | 2 | 2023 | 3929 | 0.140 |
Why?
|
Public Policy | 1 | 2021 | 560 | 0.140 |
Why?
|
California | 1 | 2020 | 1403 | 0.130 |
Why?
|
Child | 5 | 2022 | 79604 | 0.130 |
Why?
|
Family Characteristics | 1 | 2020 | 1001 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2020 | 571 | 0.120 |
Why?
|
Organizational Innovation | 1 | 2018 | 535 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 1 | 2020 | 910 | 0.120 |
Why?
|
Allergens | 1 | 2022 | 1398 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Taxes | 1 | 2017 | 222 | 0.120 |
Why?
|
Food Supply | 1 | 2020 | 530 | 0.120 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.120 |
Why?
|
Baths | 1 | 2014 | 53 | 0.120 |
Why?
|
Cathepsin G | 1 | 2014 | 31 | 0.120 |
Why?
|
Health Services | 1 | 2019 | 754 | 0.120 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2014 | 61 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1137 | 0.120 |
Why?
|
Water Microbiology | 1 | 2014 | 115 | 0.110 |
Why?
|
RNA, Viral | 1 | 2022 | 2837 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1722 | 0.110 |
Why?
|
Age Factors | 2 | 2020 | 18391 | 0.110 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2014 | 88 | 0.110 |
Why?
|
Medicine | 1 | 2021 | 943 | 0.110 |
Why?
|
Cities | 1 | 2015 | 538 | 0.110 |
Why?
|
Educational Status | 1 | 2020 | 2512 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2018 | 882 | 0.110 |
Why?
|
Vital Capacity | 1 | 2015 | 964 | 0.110 |
Why?
|
Cost of Illness | 1 | 2022 | 1937 | 0.100 |
Why?
|
Logistic Models | 2 | 2018 | 13309 | 0.100 |
Why?
|
Incidence | 2 | 2022 | 21344 | 0.100 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7788 | 0.100 |
Why?
|
Hypercalcemia | 1 | 2014 | 418 | 0.100 |
Why?
|
Pregnancy | 2 | 2023 | 29650 | 0.090 |
Why?
|
Health Care Costs | 1 | 2024 | 3253 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1807 | 0.090 |
Why?
|
Smoke | 1 | 2012 | 236 | 0.090 |
Why?
|
Drug Costs | 1 | 2018 | 1183 | 0.090 |
Why?
|
Protein Phosphatase 2 | 1 | 2012 | 236 | 0.090 |
Why?
|
Massachusetts | 1 | 2023 | 8788 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7247 | 0.080 |
Why?
|
Child, Preschool | 2 | 2021 | 41932 | 0.080 |
Why?
|
Forecasting | 1 | 2016 | 2928 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10515 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2580 | 0.070 |
Why?
|
Software | 1 | 2020 | 4421 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4527 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8435 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5876 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3460 | 0.060 |
Why?
|
Occupational Exposure | 1 | 2015 | 1806 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15815 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 8001 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12152 | 0.050 |
Why?
|
Pneumonia | 1 | 2014 | 2139 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3531 | 0.050 |
Why?
|
Depression | 1 | 2021 | 8026 | 0.050 |
Why?
|
Infant | 1 | 2021 | 35940 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3045 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 412 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 74167 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 924 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17748 | 0.030 |
Why?
|
Language | 1 | 2021 | 1525 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2014 | 750 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 633 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1563 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2018 | 80125 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1631 | 0.020 |
Why?
|
Rare Diseases | 1 | 2014 | 619 | 0.020 |
Why?
|
Emphysema | 1 | 2012 | 240 | 0.020 |
Why?
|
Animals | 3 | 2015 | 167531 | 0.020 |
Why?
|
Hot Temperature | 1 | 2014 | 1434 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1293 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 1000 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4079 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2214 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3604 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3123 | 0.020 |
Why?
|
Models, Animal | 1 | 2012 | 2113 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2486 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3443 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6538 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3664 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11046 | 0.010 |
Why?
|
Vitamin D | 1 | 2014 | 3291 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41266 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18937 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54190 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7290 | 0.010 |
Why?
|
Mice | 2 | 2014 | 80993 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10746 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21892 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 24049 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20461 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23328 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 64867 | 0.000 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_